Padegimas Eric M, Merkow David, Nicholson Thema A, Lazarus Mark D, Ramsey Matthew L, Williams Gerald R, Namdari Surena
Department of Orthopaedic Surgery, Thomas Jefferson University Hospitals, Philadelphia, USA.
Sidney Kimmel Medical College, Thomas Jefferson University Hospitals, Philadelphia, USA.
Shoulder Elbow. 2019 Oct;11(5):344-352. doi: 10.1177/1758573218780519. Epub 2018 Jun 13.
Shoulder arthroplasty with previous axillary lymph node dissection historically has unsatisfactory outcomes. We analyzed outcomes of primary shoulder arthroplasty in patients with previous axillary lymph node dissection.
Thirty-two primary shoulder arthroplasties after prior axillary lymph node dissection were performed. These patients were analyzed for patient-reported outcomes, range of motion, complications, and reoperations.
Average age was 70.8 ± 7.5 years old. There were 19 anatomic total shoulder arthroplasties, four hemiarthroplasties, and nine reverse total shoulder arthroplasties. Eight were performed by a superior approach while 24 were performed by a deltopectoral approach with cephalic vein preservation. There were three complications (one deltoid dehiscence, one axillary nerve palsy, and one postoperative pneumonia). There was one revision (hemiarthroplasty to reverse total shoulder arthroplasty for cuff failure at 91 weeks), two reoperations, and no infections. Patient-reported outcomes were available for 21/26 (80.1%) of the surviving shoulders at 4.8 ± 2.0 years. Average visual analog scale pain score was 7.1 ± 14.5, Simple Shoulder Test score 8.3 ± 2.6 "yes" responses, Single Assessment Numeric Evaluation score 80.2 ± 17.4, and American Shoulder and Elbow Surgeons score 83.6 ± 14.1.
Axillary lymph node dissection is not a contraindication to shoulder arthroplasty. A deltopectoral exposure can be utilized without substantial risk of worsening lymphedema or wound complications. While a superior approach avoids cephalic vein injury, important approach-related complications (deltoid dehiscence and axillary nerve palsy) were observed. Level IV-case series.
既往有腋窝淋巴结清扫史的患者行肩关节置换术,其历史疗效并不理想。我们分析了既往有腋窝淋巴结清扫史的患者行初次肩关节置换术的疗效。
对32例既往有腋窝淋巴结清扫史后行初次肩关节置换术的患者进行分析。分析这些患者的患者报告结局、活动范围、并发症及再次手术情况。
平均年龄为70.8±7.5岁。其中解剖型全肩关节置换术19例,半肩关节置换术4例,反式全肩关节置换术9例。8例采用上方入路,24例采用保留头静脉的胸大肌三角肌入路。发生3例并发症(1例三角肌裂开、1例腋神经麻痹和1例术后肺炎)。有1例翻修手术(91周时因肩袖功能障碍将半肩关节置换术翻修为反式全肩关节置换术),2例再次手术,无感染发生。在4.8±2.0年时,21/26(80.1%)存活肩关节有患者报告结局。平均视觉模拟评分疼痛评分为7.1±14.5,简易肩关节测试评分“是”的回答为8.3±2.6,单项评估数字评价评分为80.2±17.4,美国肩肘外科医师协会评分为83.6±14.1。
腋窝淋巴结清扫不是肩关节置换术的禁忌证。胸大肌三角肌入路可在不显著增加淋巴水肿或伤口并发症风险的情况下使用。虽然上方入路可避免头静脉损伤,但观察到了与入路相关的重要并发症(三角肌裂开和腋神经麻痹)。IV级病例系列。